COMPARATIVE STUDY OF HYPERBARIC ROPIVACAINE (0.75%) AND HYPERBARIC BUPIVACAINE (0.5%) FOR DAY CARE PERINEAL SURGERIES UNDER SPINAL ANAESTHESIA
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/03/051019
- Lead Sponsor
- DR ASHOK KULASEKAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.American society of Anaesthesiologists(ASA) grade I-II,
2.Age group between 18-65 years of both sexes.
3. Scheduled for Perineal surgeries under spinal Anaesthesia with expected duration of surgery less than 90 minutes.
Exclusion Criteria
1.Patient refusal
2.History of allergy to test drug
3.Post spinal surgeries, spinal deformities, skin sepsis in lumbar region, patient with pre-existing neurological disorders
4.coagulopathy
5.Dysrhythmia
6.Major Hepatic, renal and cardiovascular dysfunction.
7.BMI >35
8.Height <140 cm
9.Surgeries involving major blood loss.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of motor blockTimepoint: Patient is placed in sitting position for 15 minutes following the test drug administration via subarachnoid block .Duration of motor block will be assessed from baseline-15 minutes from the time of administering the test drug, and 20 minutes, followed by every 30 minutes interval upto 200 minutes.
- Secondary Outcome Measures
Name Time Method Highest level of sensory blockTimepoint: Duration of sensory block will be assessed from baseline-15 minutes from the time of administering the test drug, and 20 minutes, followed by every 30 minutes interval upto 200 minutes.;To assess Hemodynamic changes and side effects, if anyTimepoint: Patients heart rate, NIBP, SPO2 will be monitored at 3 minute interval up to 15 minutes then every 5 minutes up to 60 minutes then every 10 minutes till the end of the procedure.